Fluoropolymer-coated Dacron Versus PTFE Grafts for Femorofemoral Crossover Bypass: Randomised Trial
To investigate whether patency of a thin walled 8 mm fluoropassivated Dacron graft was similar to that of a standard 8 mm PTFE graft for femorofemoral crossover bypass surgery. A randomised multicentre clinical trial comparing two vascular grafts with participation of 10 departments of vascular surg...
Gespeichert in:
| Veröffentlicht in: | European journal of vascular and endovascular surgery 2006-10, Vol.32 (4), p.431-438 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 438 |
|---|---|
| container_issue | 4 |
| container_start_page | 431 |
| container_title | European journal of vascular and endovascular surgery |
| container_volume | 32 |
| creator | Eiberg, J.P. Røder, O. Stahl-Madsen, M. Eldrup, N. Qvarfordt, P. Laursen, A. Greve, M. Flörenes, T. Nielsen, O.M. Seidelin, C. Vestergaard-Andersen, T. Schroeder, T.V. |
| description | To investigate whether patency of a thin walled 8
mm fluoropassivated Dacron graft was similar to that of a standard 8
mm PTFE graft for femorofemoral crossover bypass surgery.
A randomised multicentre clinical trial comparing two vascular grafts with participation of 10 departments of vascular surgery in Denmark, Sweden and Norway.
198 patients were randomised to PTFE (
n
=
107) or fluoropolymer-coated Dacron grafts (
n
=
91), 63% underwent surgery for claudication, 27% for ischaemic rest pain and 10% for tissue loss. The median follow-up time was 24 months (IQR 19–26 months).
The primary patency rate of the two grafts was similar (log rank test:
p
=
0.35). The primary patency rates (95% CI) for coated Dacron and PTFE grafts were 92% (86–98) and 94% (89–99) at 12 months and 87% (74–95) and 93% (87–99) at 24 months, respectively.
In patients with unilateral iliac artery disease not amenable to angioplasty, the femoral-femoral bypass is durable and effective. No difference in patency was found between the two graft materials (fluoropolymer coated Dacron and PTFE). |
| doi_str_mv | 10.1016/j.ejvs.2006.04.018 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68857663</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1078588406002206</els_id><sourcerecordid>68857663</sourcerecordid><originalsourceid>FETCH-LOGICAL-c398t-ee976a71fcc0ee234dc012edbe0a55f10cc8dc8217b4ef2f109e3b6eb22ab8353</originalsourceid><addsrcrecordid>eNp9kE9LxDAQxYMo_v8CHiQnb62TtEmz4kXXXRUERVavIU2n0KXdrEm7sN_elF3w5mVmGN57zPwIuWKQMmDydpnichNSDiBTyFNg6oCcMpHxhDMpDuMMhUqEUvkJOQthCQCCZeKYnDCpoABgp8TO28F5t3bttkOfWGd6rOiTsd6t6Df6MAT6sZjP6LM3dR9o7TydYxct9VhNS6feheA26Onjdm1CuKOfZlW5rgkxaOEb016Qo9q0AS_3_Zx8zWeL6Uvy9v78On14S2w2UX2COCmkKVhtLSDyLK8sMI5ViWCEqBlYqyqrOCvKHGseFxPMSokl56ZUmcjOyc0ud-3dz4Ch1_EIi21rVuiGoKVSopAyi0K-E9rxdo-1XvumM36rGegRrV7qEa0e0WrIdUQbTdf79KHssPqz7FlGwf1OgPHHTYNeB9vgymLVeLS9rlzzX_4vQPOMaw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68857663</pqid></control><display><type>article</type><title>Fluoropolymer-coated Dacron Versus PTFE Grafts for Femorofemoral Crossover Bypass: Randomised Trial</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><source>EZB Electronic Journals Library</source><creator>Eiberg, J.P. ; Røder, O. ; Stahl-Madsen, M. ; Eldrup, N. ; Qvarfordt, P. ; Laursen, A. ; Greve, M. ; Flörenes, T. ; Nielsen, O.M. ; Seidelin, C. ; Vestergaard-Andersen, T. ; Schroeder, T.V.</creator><creatorcontrib>Eiberg, J.P. ; Røder, O. ; Stahl-Madsen, M. ; Eldrup, N. ; Qvarfordt, P. ; Laursen, A. ; Greve, M. ; Flörenes, T. ; Nielsen, O.M. ; Seidelin, C. ; Vestergaard-Andersen, T. ; Schroeder, T.V.</creatorcontrib><description>To investigate whether patency of a thin walled 8
mm fluoropassivated Dacron graft was similar to that of a standard 8
mm PTFE graft for femorofemoral crossover bypass surgery.
A randomised multicentre clinical trial comparing two vascular grafts with participation of 10 departments of vascular surgery in Denmark, Sweden and Norway.
198 patients were randomised to PTFE (
n
=
107) or fluoropolymer-coated Dacron grafts (
n
=
91), 63% underwent surgery for claudication, 27% for ischaemic rest pain and 10% for tissue loss. The median follow-up time was 24 months (IQR 19–26 months).
The primary patency rate of the two grafts was similar (log rank test:
p
=
0.35). The primary patency rates (95% CI) for coated Dacron and PTFE grafts were 92% (86–98) and 94% (89–99) at 12 months and 87% (74–95) and 93% (87–99) at 24 months, respectively.
In patients with unilateral iliac artery disease not amenable to angioplasty, the femoral-femoral bypass is durable and effective. No difference in patency was found between the two graft materials (fluoropolymer coated Dacron and PTFE).</description><identifier>ISSN: 1078-5884</identifier><identifier>EISSN: 1532-2165</identifier><identifier>DOI: 10.1016/j.ejvs.2006.04.018</identifier><identifier>PMID: 16807001</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Aged ; Blood Vessel Prosthesis - adverse effects ; Blood Vessel Prosthesis Implantation - adverse effects ; Coated Materials, Biocompatible ; Female ; Femoral Artery - surgery ; Femorofemoral bypass ; Fluorocarbon Polymers ; Fluoropassivated Dacron ; Graft Occlusion, Vascular - etiology ; Humans ; Intermittent Claudication - surgery ; Ischemia - surgery ; Leg - blood supply ; Male ; Patency ; Polyethylene Terephthalates ; Polytetrafluoroethylene ; Postoperative Complications ; PTFE ; Risk Factors ; Vascular Patency</subject><ispartof>European journal of vascular and endovascular surgery, 2006-10, Vol.32 (4), p.431-438</ispartof><rights>2006 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c398t-ee976a71fcc0ee234dc012edbe0a55f10cc8dc8217b4ef2f109e3b6eb22ab8353</citedby><cites>FETCH-LOGICAL-c398t-ee976a71fcc0ee234dc012edbe0a55f10cc8dc8217b4ef2f109e3b6eb22ab8353</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejvs.2006.04.018$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3541,27915,27916,45986</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16807001$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Eiberg, J.P.</creatorcontrib><creatorcontrib>Røder, O.</creatorcontrib><creatorcontrib>Stahl-Madsen, M.</creatorcontrib><creatorcontrib>Eldrup, N.</creatorcontrib><creatorcontrib>Qvarfordt, P.</creatorcontrib><creatorcontrib>Laursen, A.</creatorcontrib><creatorcontrib>Greve, M.</creatorcontrib><creatorcontrib>Flörenes, T.</creatorcontrib><creatorcontrib>Nielsen, O.M.</creatorcontrib><creatorcontrib>Seidelin, C.</creatorcontrib><creatorcontrib>Vestergaard-Andersen, T.</creatorcontrib><creatorcontrib>Schroeder, T.V.</creatorcontrib><title>Fluoropolymer-coated Dacron Versus PTFE Grafts for Femorofemoral Crossover Bypass: Randomised Trial</title><title>European journal of vascular and endovascular surgery</title><addtitle>Eur J Vasc Endovasc Surg</addtitle><description>To investigate whether patency of a thin walled 8
mm fluoropassivated Dacron graft was similar to that of a standard 8
mm PTFE graft for femorofemoral crossover bypass surgery.
A randomised multicentre clinical trial comparing two vascular grafts with participation of 10 departments of vascular surgery in Denmark, Sweden and Norway.
198 patients were randomised to PTFE (
n
=
107) or fluoropolymer-coated Dacron grafts (
n
=
91), 63% underwent surgery for claudication, 27% for ischaemic rest pain and 10% for tissue loss. The median follow-up time was 24 months (IQR 19–26 months).
The primary patency rate of the two grafts was similar (log rank test:
p
=
0.35). The primary patency rates (95% CI) for coated Dacron and PTFE grafts were 92% (86–98) and 94% (89–99) at 12 months and 87% (74–95) and 93% (87–99) at 24 months, respectively.
In patients with unilateral iliac artery disease not amenable to angioplasty, the femoral-femoral bypass is durable and effective. No difference in patency was found between the two graft materials (fluoropolymer coated Dacron and PTFE).</description><subject>Aged</subject><subject>Blood Vessel Prosthesis - adverse effects</subject><subject>Blood Vessel Prosthesis Implantation - adverse effects</subject><subject>Coated Materials, Biocompatible</subject><subject>Female</subject><subject>Femoral Artery - surgery</subject><subject>Femorofemoral bypass</subject><subject>Fluorocarbon Polymers</subject><subject>Fluoropassivated Dacron</subject><subject>Graft Occlusion, Vascular - etiology</subject><subject>Humans</subject><subject>Intermittent Claudication - surgery</subject><subject>Ischemia - surgery</subject><subject>Leg - blood supply</subject><subject>Male</subject><subject>Patency</subject><subject>Polyethylene Terephthalates</subject><subject>Polytetrafluoroethylene</subject><subject>Postoperative Complications</subject><subject>PTFE</subject><subject>Risk Factors</subject><subject>Vascular Patency</subject><issn>1078-5884</issn><issn>1532-2165</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE9LxDAQxYMo_v8CHiQnb62TtEmz4kXXXRUERVavIU2n0KXdrEm7sN_elF3w5mVmGN57zPwIuWKQMmDydpnichNSDiBTyFNg6oCcMpHxhDMpDuMMhUqEUvkJOQthCQCCZeKYnDCpoABgp8TO28F5t3bttkOfWGd6rOiTsd6t6Df6MAT6sZjP6LM3dR9o7TydYxct9VhNS6feheA26Onjdm1CuKOfZlW5rgkxaOEb016Qo9q0AS_3_Zx8zWeL6Uvy9v78On14S2w2UX2COCmkKVhtLSDyLK8sMI5ViWCEqBlYqyqrOCvKHGseFxPMSokl56ZUmcjOyc0ud-3dz4Ch1_EIi21rVuiGoKVSopAyi0K-E9rxdo-1XvumM36rGegRrV7qEa0e0WrIdUQbTdf79KHssPqz7FlGwf1OgPHHTYNeB9vgymLVeLS9rlzzX_4vQPOMaw</recordid><startdate>20061001</startdate><enddate>20061001</enddate><creator>Eiberg, J.P.</creator><creator>Røder, O.</creator><creator>Stahl-Madsen, M.</creator><creator>Eldrup, N.</creator><creator>Qvarfordt, P.</creator><creator>Laursen, A.</creator><creator>Greve, M.</creator><creator>Flörenes, T.</creator><creator>Nielsen, O.M.</creator><creator>Seidelin, C.</creator><creator>Vestergaard-Andersen, T.</creator><creator>Schroeder, T.V.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20061001</creationdate><title>Fluoropolymer-coated Dacron Versus PTFE Grafts for Femorofemoral Crossover Bypass: Randomised Trial</title><author>Eiberg, J.P. ; Røder, O. ; Stahl-Madsen, M. ; Eldrup, N. ; Qvarfordt, P. ; Laursen, A. ; Greve, M. ; Flörenes, T. ; Nielsen, O.M. ; Seidelin, C. ; Vestergaard-Andersen, T. ; Schroeder, T.V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c398t-ee976a71fcc0ee234dc012edbe0a55f10cc8dc8217b4ef2f109e3b6eb22ab8353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Aged</topic><topic>Blood Vessel Prosthesis - adverse effects</topic><topic>Blood Vessel Prosthesis Implantation - adverse effects</topic><topic>Coated Materials, Biocompatible</topic><topic>Female</topic><topic>Femoral Artery - surgery</topic><topic>Femorofemoral bypass</topic><topic>Fluorocarbon Polymers</topic><topic>Fluoropassivated Dacron</topic><topic>Graft Occlusion, Vascular - etiology</topic><topic>Humans</topic><topic>Intermittent Claudication - surgery</topic><topic>Ischemia - surgery</topic><topic>Leg - blood supply</topic><topic>Male</topic><topic>Patency</topic><topic>Polyethylene Terephthalates</topic><topic>Polytetrafluoroethylene</topic><topic>Postoperative Complications</topic><topic>PTFE</topic><topic>Risk Factors</topic><topic>Vascular Patency</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Eiberg, J.P.</creatorcontrib><creatorcontrib>Røder, O.</creatorcontrib><creatorcontrib>Stahl-Madsen, M.</creatorcontrib><creatorcontrib>Eldrup, N.</creatorcontrib><creatorcontrib>Qvarfordt, P.</creatorcontrib><creatorcontrib>Laursen, A.</creatorcontrib><creatorcontrib>Greve, M.</creatorcontrib><creatorcontrib>Flörenes, T.</creatorcontrib><creatorcontrib>Nielsen, O.M.</creatorcontrib><creatorcontrib>Seidelin, C.</creatorcontrib><creatorcontrib>Vestergaard-Andersen, T.</creatorcontrib><creatorcontrib>Schroeder, T.V.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of vascular and endovascular surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Eiberg, J.P.</au><au>Røder, O.</au><au>Stahl-Madsen, M.</au><au>Eldrup, N.</au><au>Qvarfordt, P.</au><au>Laursen, A.</au><au>Greve, M.</au><au>Flörenes, T.</au><au>Nielsen, O.M.</au><au>Seidelin, C.</au><au>Vestergaard-Andersen, T.</au><au>Schroeder, T.V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fluoropolymer-coated Dacron Versus PTFE Grafts for Femorofemoral Crossover Bypass: Randomised Trial</atitle><jtitle>European journal of vascular and endovascular surgery</jtitle><addtitle>Eur J Vasc Endovasc Surg</addtitle><date>2006-10-01</date><risdate>2006</risdate><volume>32</volume><issue>4</issue><spage>431</spage><epage>438</epage><pages>431-438</pages><issn>1078-5884</issn><eissn>1532-2165</eissn><abstract>To investigate whether patency of a thin walled 8
mm fluoropassivated Dacron graft was similar to that of a standard 8
mm PTFE graft for femorofemoral crossover bypass surgery.
A randomised multicentre clinical trial comparing two vascular grafts with participation of 10 departments of vascular surgery in Denmark, Sweden and Norway.
198 patients were randomised to PTFE (
n
=
107) or fluoropolymer-coated Dacron grafts (
n
=
91), 63% underwent surgery for claudication, 27% for ischaemic rest pain and 10% for tissue loss. The median follow-up time was 24 months (IQR 19–26 months).
The primary patency rate of the two grafts was similar (log rank test:
p
=
0.35). The primary patency rates (95% CI) for coated Dacron and PTFE grafts were 92% (86–98) and 94% (89–99) at 12 months and 87% (74–95) and 93% (87–99) at 24 months, respectively.
In patients with unilateral iliac artery disease not amenable to angioplasty, the femoral-femoral bypass is durable and effective. No difference in patency was found between the two graft materials (fluoropolymer coated Dacron and PTFE).</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>16807001</pmid><doi>10.1016/j.ejvs.2006.04.018</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1078-5884 |
| ispartof | European journal of vascular and endovascular surgery, 2006-10, Vol.32 (4), p.431-438 |
| issn | 1078-5884 1532-2165 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68857663 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete; EZB Electronic Journals Library |
| subjects | Aged Blood Vessel Prosthesis - adverse effects Blood Vessel Prosthesis Implantation - adverse effects Coated Materials, Biocompatible Female Femoral Artery - surgery Femorofemoral bypass Fluorocarbon Polymers Fluoropassivated Dacron Graft Occlusion, Vascular - etiology Humans Intermittent Claudication - surgery Ischemia - surgery Leg - blood supply Male Patency Polyethylene Terephthalates Polytetrafluoroethylene Postoperative Complications PTFE Risk Factors Vascular Patency |
| title | Fluoropolymer-coated Dacron Versus PTFE Grafts for Femorofemoral Crossover Bypass: Randomised Trial |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T18%3A02%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fluoropolymer-coated%20Dacron%20Versus%20PTFE%20Grafts%20for%20Femorofemoral%20Crossover%20Bypass:%20Randomised%20Trial&rft.jtitle=European%20journal%20of%20vascular%20and%20endovascular%20surgery&rft.au=Eiberg,%20J.P.&rft.date=2006-10-01&rft.volume=32&rft.issue=4&rft.spage=431&rft.epage=438&rft.pages=431-438&rft.issn=1078-5884&rft.eissn=1532-2165&rft_id=info:doi/10.1016/j.ejvs.2006.04.018&rft_dat=%3Cproquest_cross%3E68857663%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68857663&rft_id=info:pmid/16807001&rft_els_id=S1078588406002206&rfr_iscdi=true |